RevolutionEHR, the leading provider of cloud-based practice management and electronic health record software for the optometric community, is pleased to announce integration with the Essilor Visioffice®, Visioffice® 2, m’eyeFit™ and m’eyeFit™ mirror systems.
With the integration, RevolutionEHR customers can further enhance their delivery of patient care by saving optical staff time while decreasing the likelihood of data entry errors.
“For our Visioffice and m’eyeFit system users, this integration delivers seamless transmission of the recorded patient measurement data directly into the RevolutionEHR patient spectacle Rx form.” said Lauri Crawford, senior vice president of marketing, Essilor of America. “Improved efficiency within the measurement workflow will ensure the primary focus remains on the patient, providing each individual with the personalized eye care experience they deserve.”
RevolutionEHR customers are offered the integration at no additional cost and can get started in minutes.
“Our customers look to us to consistently add value to RevolutionEHR” said Dr. Scott Jens, CEO of RevolutionEHR. “This seamless connection with Essilor digital measuring devices to the RevolutionEHR order screen brings additional efficiencies and provides a unique patient experience in the dispensary.”
Essilor is the leading manufacturer of optical lenses in the United States and is the market leader in progressive, high-index, photochromic and anti-reflective coated lenses. A pioneer in the development and production of ophthalmic lenses, Essilor employs more than 10,000 people throughout North America. Essilor manufactures optical lenses under the VARILUX®, CRIZAL®, TRANSITIONS®, XPERIO UV™, DEFINITY®, THIN&LITE® and other Essilor brand names. Essilor Laboratories of America, Inc. is the largest, and most trusted, optical lab network in the U.S. and offers a wide choice of services and lens brands, including Essilor premium lenses, to eyecare professionals across the nation. Essilor of America, Inc. (Essilor) is a subsidiary of Paris-based Essilor International, a publicly held company traded on the Euronext Paris stock exchange (Reuters: ESSI.PA).